News Headlines Article

FDA forms task force on antibacterial drugs
Modern Healthcare

The Food and Drug Administration said it has formed an internal task force to aid the development of new antibacterial drugs. The creation of the Antibacterial Drug Development Task Force stems from a provision in the user-fee legislation that was signed into law in July. The Generating Antibiotic Incentives Now provision requires the FDA to extend exclusivity periods for antibiotic drugs, as well as provide priority review to designated infectious disease products.